METHODS OF DETECTING Lp-PLA2 ACTIVITY

WIPO Patent Application WO2005074604

A3

This invention relates to a method for measuring enzymatically active Lipoprotein­associated Phospholipase A2 (Lp-PLA2) in a sample. Further, this invention relates to a Hybrid Immunocapture method for measuring enzymatically active Lp-PLA2 in a sample. Specifically, this invention relates to a Hybrid Immunocapture method for measuring enzymatically active Lp-PLA2 in a sample utilizing an enzymatically active Lp-PLA2 standard. In addition, this invention relates to a kit for measuring enzymatically active Lp­PLA2 in a sample. Specifically, this invention relates to a kit for measuring enzymatically active Lp-PLA2 in a sample containing an enzymatically active Lp-PLA2 standard.

WO/2017/152857	INDOLEAMINE-2,3-DIOXYGENASE INHIBITOR CONTAINING NITROGEN ALKYLATED AND ARYLATED SULPHOXIDE IMINES
JP6088047	Neprilysin inhibitor which is a nitric oxide donor
JP7301856	Indoleamine-2,3-dioxygenase inhibitor and its preparation and use

WOLFERT ROBERT L (US)
KIM NAM (US)
DUAN XIAOZHU (US)

PCT/US2005/003211

December 29, 2005

February 03, 2005

Click for automatic bibliography generation  

DIADEXUS INC (US)
WOLFERT ROBERT L (US)
KIM NAM (US)
DUAN XIAOZHU (US)

C07D271/08; C07K16/00; C12Q1/44; G01N33/53; G01N33/573; (IPC1-7): G01N33/53; G01N33/573; C07K16/00

US20020177209A1

2002-11-28

KUJIRAOKA ET AL: "Altered distribution of plasma PAF-AH between HDLs and other lipoproteins in hyperlipidemia and diabetes mellitus.", JOURNAL OF LIPID RESEARCH., vol. 44, 2003, pages 2006 - 2014, XP008092123
KOSAKA ET AL: "Spectrophotometric assay for serum platelet-activating factor acetylhydrolase activity.", CLINICA CHIMICA ACTA., vol. 296, 2000, pages 151 - 161, XP002997443

View/Download PDF      PDF Help

Previous Patent: AMINOBENZOXAZOLES AS THERAPEUTIC AGENTS

Next Patent: RECOMBINANT MOLECULAR PRODUCTS FOR EXPRESSION OF HEME OXYGENASE-1, HEME OXYGENASE-2, AND/OR BILIVERD...